Mesoblast (MESO) announced Ryoncil net sales were $30.3M for the quarter ended March 31. Strong sales in February and March offset holiday seasonality in January. Revenue generated during this first year of Ryoncil launch approaches $100M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MESO:
- Mesoblast reports March quarter Ryoncil sales of $30.3M
- Largest borrow rate increases among liquid names
- Mesoblast Grants New Director Options Following 2025 AGM Approvals
- Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
- Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs